ES555601A0 - Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico - Google Patents

Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Info

Publication number
ES555601A0
ES555601A0 ES555601A ES555601A ES555601A0 ES 555601 A0 ES555601 A0 ES 555601A0 ES 555601 A ES555601 A ES 555601A ES 555601 A ES555601 A ES 555601A ES 555601 A0 ES555601 A0 ES 555601A0
Authority
ES
Spain
Prior art keywords
levogiro
antipoda
dextrogiro
sulfonil
benzodioxol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555601A
Other languages
English (en)
Other versions
ES8800922A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8800922A1 publication Critical patent/ES8800922A1/es
Publication of ES555601A0 publication Critical patent/ES555601A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES555601A 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico Expired ES8800922A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH175284 1984-04-06

Publications (2)

Publication Number Publication Date
ES8800922A1 ES8800922A1 (es) 1987-12-01
ES555601A0 true ES555601A0 (es) 1987-12-01

Family

ID=4217732

Family Applications (4)

Application Number Title Priority Date Filing Date
ES541965A Expired ES8800192A1 (es) 1984-04-06 1985-04-03 Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.
ES555599A Expired ES8800921A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555601A Expired ES8800922A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555600A Expired ES8706662A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES541965A Expired ES8800192A1 (es) 1984-04-06 1985-04-03 Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.
ES555599A Expired ES8800921A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES555600A Expired ES8706662A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Country Status (11)

Country Link
EP (1) EP0158596A3 (es)
JP (1) JPS60228473A (es)
AU (1) AU4089185A (es)
DK (1) DK153285A (es)
ES (4) ES8800192A1 (es)
FI (1) FI851335L (es)
GR (1) GR850845B (es)
IL (1) IL74780A0 (es)
NO (1) NO851385L (es)
PT (1) PT80222B (es)
ZA (1) ZA852554B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585172C (en) 2004-10-29 2014-08-12 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as modulators of ppar
HUE040020T2 (hu) 2005-10-25 2019-02-28 Kalypsys Inc PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75464B (es) * 1981-04-24 1984-07-20 Ciba Geigy
ATE30722T1 (de) * 1982-10-22 1987-11-15 Ciba Geigy Ag Neue benzodioxolderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
GR850845B (es) 1985-11-25
ES8800921A1 (es) 1987-12-01
ES8800192A1 (es) 1987-11-01
AU4089185A (en) 1985-10-10
ES555600A0 (es) 1987-07-01
JPS60228473A (ja) 1985-11-13
FI851335A0 (fi) 1985-04-03
DK153285D0 (da) 1985-04-03
EP0158596A2 (de) 1985-10-16
ZA852554B (en) 1985-11-27
ES8800922A1 (es) 1987-12-01
ES555599A0 (es) 1987-12-01
ES541965A0 (es) 1987-11-01
PT80222B (en) 1987-04-13
FI851335L (fi) 1985-10-07
PT80222A (en) 1985-05-01
NO851385L (no) 1985-10-07
IL74780A0 (en) 1985-07-31
EP0158596A3 (de) 1986-08-13
DK153285A (da) 1985-10-07
ES8706662A1 (es) 1987-07-01

Similar Documents

Publication Publication Date Title
ES553083A0 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico
ES552397A0 (es) Procedimiento para la obtencion de poli-hidro piridazo diacepinas, triacepinas o diazocinas
ES549587A0 (es) Procedimiento para la fabricacion de nuevos derivados nu- cleosidos
ES524582A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos (di)-tiofosforicos y fosfonicos.
ES534924A0 (es) Procedimiento para la obtencion de monoeteres alifaticos del 2,2-dimetilpropan-1,3-diol
ES537480A0 (es) Procedimiento para la fabricacion de la reductasa del acido 2, 5-diceto-d-gluconico
ES555599A0 (es) Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES540173A0 (es) Procedimiento para la obtencion de nuevos 1,3,2-dioxaborina-nos
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
ES540147A0 (es) Procedimiento para la obtencion del 2-(2-(3,5-dimetil-4-me- toxi)piridilmetil sulfonil)-5-metoxibenzimidazol
ES539626A0 (es) Procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil-o-n-pirazinil propilaminas.
ES545068A0 (es) Procedimiento para la fabricacion de derivados del acido aminotiazolilpropandicarboxilico
ES541295A0 (es) Procedimiento para preparar isocromanos y oxepinas, susti- tuidos
ES550034A0 (es) Procedimiento para la fabricacion de dispositivos semicon- ductores
ES543210A0 (es) Procedimiento para la obtencion del acido 1-etil-6-fluoro- 1,4-dihidro-4-oxo-7-(1-piperacinil)-1,8 naftiridin-3-carbo- xilico
ES526304A0 (es) Procedimiento para la obtencion del 8-(4-(4-(2-pirimidinil)-1-piperazinil)butil)-8-azaspiro(4,5)decano-7,9-diona
ES532393A0 (es) Procedimiento para la preparacion del citrato de la (+) vinpocetina
MX8938A (es) Nuevos derivados del acido 1,5-difenilpirazol-3-carboxilico y procedimiento para su preparacion
ES536268A0 (es) Procedimiento para la obtencion del 8-(4-(4-(2-pirimidil)-1-piperacinil)butil)-8-azaspiro (5,4)-decan-7,9-diona
ES534473A0 (es) Procedimiento para la obtencion del acido 2, 2-dimetil-5(2, 5-xililoxi) valerico
ES543209A0 (es) Procedimiento para la obtencion del acido 1-ciclopropil-6- fluoro-1,4-dihidro-4-oxo-7-(1-piperacinil)-3-quinolincarbo- xilico
ES553521A0 (es) Procedimiento para la obtencion del acido 1-ciclopropil-1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolincarbolixo
ES542441A0 (es) "procedimiento para la obtencion del acido 1-ciclopropil-6- fluor--1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolincarbo- xilico".
ES549368A0 (es) Procedimiento para la fabricacion de (-hidroxacidos
ES537072A0 (es) Procedimiento para la obtencion del acido 1-etil-6-fluoro-1, 4-dihidro-4-oxi-7-(1-piperacinil)3-quinolincarboxilico